Abstract
Inflammatory bowel disease (IBD) can be a multisystemic disease involving other organs besides the gastrointestinal tract. Approximately one third of patients with Crohn’s disease and ulcerative colitis have some extraintestinal disease manifestation. Most often this involves the eyes, skin, joints, kidneys, and liver but well over 100 extraintestinal manifestations have been reported. Since these manifestations can be the presenting symptom, instead of the classic bowel symptoms, in some patients, knowledge about them is critical. Further, extraintestinal manifestations of IBD are a cause of major morbidity in patients and need to be considered and addressed at all points of care. The more common extraintestinal manifestations found in the pediatric population with IBD will be presented in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Levine JB, Lukawski-Trubish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24:633.
Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology. 1994;107:103.
Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel disease. World J Gastroenterol. 2006;12:4819.
Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol. 2006;6:244.
Lofberg R, Louis EV, Reinish W, Robinson AM, Kron M, Camez A, et al. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn disease: results from CARE. Inflamm Bowel Dis. 2012;18:1–9.
Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227.
Oliva-Hemker M. More than a gut reaction: extraintestinal complications of IBD. Contemp Pediatr. 1999;16:45.
Vavricka SR, Brun L, Ballabeni P, Pittet V, Vavricka BMP, Zeitz J, et al. Cohort Study Group. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.
Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63–8.
Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. JPGN. 2010;51:140–5.
Lichtman SN, Sartor RB. Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and natural history. In: Targan S, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore, MD: Williams & Wilkins; 1994.
Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19:7.
Kethu SR. Extraintestinal manifestations of inflammatory bowel disease. J of Clinical Gastroenterology. 2006;40:467.
Urlep D, Mamula P, Baldassano R. Extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol. 2005;51:147.
Loftus EV. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6:506.
Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:140.
Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307.
Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. JPGN. 2008;46:124–33.
Kanof ME, Lake AM, Bayles TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn disease. Gastroenterology. 1988;95:1523.
Conklin LS, Oliva MM. Nutritional considerations in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:305–17.
Passo MH, Fitzgerald JF, Brandt KD. Arthritis associated with inflammatory bowel disease in children—relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986;31:492.
Paparo F, Bacigalupo L, Garello I, Biscaldi E, Cimmino MA, Marinaro E, Rollandi GA. Crohn disease: prevalence of intestinal and extraintestinal manifestations detected by computed tomography enterography with water enema. Abdom Imaging 2011; Epub ahead of print.
Juillerat P, Mottet C, Froehlich F, Felley C, Vader J, Burnand B, et al. Extraintestinal manifestations of Crohn disease. Digestion. 2005;71:31–6.
Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, et al. Study Group. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis. 2009;15:365–74.
Bernstein CN. Osteoporosis and other complications of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:428.
Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902.
Hyams JS, Wyzga N, Kreutzer DL, et al. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr. 1997;24:289.
Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Digestive Diseases and Science. 1999;44:2500–7.
Fatahzadeh M, Schwartz RA, Kapila R, Rochford C. Orofacial Crohn disease: an oral enigma. Acta Dermatoveneral Croat. 2009;17:289–300.
Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn disease. J Clin Gastroenterol. 1991;13:29.
Grilich C, Bogenrieder T, Palitzsch KD, Scholmerich J, Lock G. Orofacial granulomatosis as initial manifestation of Crohn disease: a report of two cases. Eur J Gastroenterol Hepatol. 2002;13: 873–6.
Storwick GS, Prihoda MB, Fulton RJ, et al. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol. 1994;31:336.
Lynde CB, Brue AJ, Rogers RS. Successful treatment of complex aphthous with colchicine and dapsone. Arch Dermatol. 2009;145:273–6.
Kugathasan S, Miranda A, Nocton J, Drolet BA, Raasch C, Binion DG. Dermatologic manifestations of Crohn disease in children: response to infliximab. J Pediatr Gastroenterol Nutr. 2003;37:150–4.
Meinhardt C, Buning J, Fellermann K, Lehnert H, Schmidt KJ. Cyclophosphamide therapy in Sweet’s syndrome complicating refractory Crohn disease – efficacy and mechanism of action. J Crohns Colitis. 2011;6:633–7.
Foo WC, Papalas JA, Robboy SJ, Selim MA. Vulvar manifestations of Crohn disease. Am J Dermatopathol. 2011;33:588–93.
Hofley P, Roarty J, McGinnity G, et al. Asymptomatic uveitis in children with chronic inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993;17:397.
SriRajaskanthan R, Winter M, Muller AF. Venous thrombosis in inflammatory bowel disease. Eur J of Gastroenterology and Hepatology. 2005;17:697.
Mader R, Segol O, Adawi M, Trougoboff P, Nussinson E. Arthritis or vasculitis as presenting symptoms of Crohn disease. Rheumatol Int. 2005;25:401–5.
Pitchumoni CS, Rubin A, Das K. Pancreatitis in inflammatory bowel disease. J Clin Gastroenterol. 2010;44:246–53.
Barthet M, Hastier P, Bernard JP, et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol. 1999;94:2141–8.
Kuzmic AC, Kolacek S, Brkljacic B, Juzjak N. Renal artery stenosis associated with Crohn disease. Pediatr Nephrol. 2001;16:371–3.
Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine. 1993;72:151.
Al-Binali AM, Scott B, Al-Garni A, Montgomery M, Robertson M. Granulomatous pulmonary disease in a child: an unusual presentation of Crohn disease. Pediatr Pulmonol. 2003;36:76–80.
Haralambou G, Teirstein AS, Gil J, Present D. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med. 2001;68:384–8.
Lossos A, River Y, Eliakim A, et al. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416.
Zois CD, Katsanos KH, Kosmidou M, Tsianos EV. Neurologic manifestations in inflammatory bowel disease: current knowledge and novel insights. J Crohns Colitis. 2010;4:115–24.
Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106: 741–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rabizadeh, S., Oliva-Hemker, M. (2013). Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease. In: Mamula, P., Markowitz, J., Baldassano, R. (eds) Pediatric Inflammatory Bowel Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5061-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5061-0_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5060-3
Online ISBN: 978-1-4614-5061-0
eBook Packages: MedicineMedicine (R0)